Ultraviolet B, vitamin D and their mechanisms in cancer prevention

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 4482, Issue , 2002, Pages 313-323

  Garland, Cedric F ^a   Garland, Frank C ^a,b   Gorham, Edward D ^a,b   Lipkin, Martin ^c   Newmark, Harold ^d   Raffa, Joseph V ^d   Holick, Michael F ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Colonic neoplasms; Epidemiology; Mechanisms; Prevention; Prostate neoplasms; Ultraviolet B radiation; Vitamin D; Vitamin D analogs

Indexed keywords

AIR POLLUTION; BIOSYNTHESIS; CLIMATOLOGY; DISEASE CONTROL; DISEASES; EPIDEMIOLOGY; LIGHT ABSORPTION; SKIN; SOLAR RADIATION; SULFUR COMPOUNDS; UPPER ATMOSPHERE; VITAMINS;

BREAST NEOPLASMS; CANCER; CANCER PREVENTION; COLONIC NEOPLASMS; DERMAL SYNTHESIS; PROSTATE NEOPLASMS; ULTRAVIOLET B; VITAMIN D;

ULTRAVIOLET RADIATION;

EID: 0036394839     PISSN: 0277786X     EISSN: None     Source Type: Journal    
DOI: 10.1117/12.452933     Document Type: Article

References (106)

1. Garland C, Garland F, Gorham E, Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 1991;54:193S-201S.
2. Lipkin M. Preclinical and early human studies of calcium and colon cancer prevention. Ann N Y Acad Sci 1999;889:120-7.
3. Lipkin M, Newmark H. Vitamin D, calcium and prevention of breast cancer. J Am Coll Nutr 1999;18:392S-397S.
4. Newmark H. Vitamin D adequacy: a possible relationship to breast cancer. In: Diet and breast cancer. New York: Plenum; 1994. p. 109-14.
5. Garland C, Garland F, Gorham E. Calcium and vitamin D: Their potential roles in cancer prevention. Ann NY Acad Sci 1999;889:107-19.
6. Janowski EL, GE Weinberg, CR Millikan, RC Schildkraut, JM Garrett, PA Hulka, BS. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Publ Hlth Nutr 1999;2(3):283-91.
7. John ES, GG Dreon, DM Koo, J. Vitamin D and breast cancer risk: The NHANES I epidemiologic follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomark Prev 1999;8:399-406.
8. Campbell MJ, Gombart, AF, Kwok SH, Park S, Koeffler HP. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene 2000;19(44):5091-7.
9. El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, et al. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 2000;60(16):4412-8.
10. Koli K, Keski-Oja J. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000;11(4):221-9.
11. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87(3):214-20.
12. Verlinden L, Verstuyf A, Van Camp M, Marcelis S, Sabbe K, Zhao XY, et al. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 2000;60(10):2673-9.
13. Sundaram S, Chaudhry M, Reardon D, Gupta M, Gewirtz DA. The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast Cancer Res Treat 2000;63(1):1-10.
14. Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R. 1,25-Dihydroxyvitamin D3 and all-transretinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 2000;60(7):2040-8.
15. Chen A, Davis BH, Bissonnette M, Scaglione-Sewell B, Brasitus TA. 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent caco-2 cell differentiation. J Biol Chem 1999;274(50):35505-13.
16. Niv Y, Sperber AD, Figer A, Igael D, Shany S, Fraser G, et al. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 1999;86(3):391-7.
17. Utiger R. The need for more vitamin D. N Engl J Med 1998;338(12):828-9.
18. Compston J. Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ 1998;317(7171):1466-7.
19. Bishop N. Rickets today--children still need milk and sunshine. N Engl J Med 1999;341(8):602-4.
20. Wharton B. Low plasma vitamin D in Asian toddlers in Britain. BMJ 1999;318(7175):2-3.
21. Garabedian M, Ben-Mekhbi H. Rickets and vitamin D deficiency. In: Holick M, editor. Vitamin D: Molecular biology, physiology and clinical applications. Totowa NJ: Humana. p. 273-86.
22. Holick M. Vitamin D and bone health. J Nutr 1996;126(4 Suppl):1159S-64S.
23. Eisman JA, Martin TJ, MacIntyre I, Moseley JM. 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet 1979;2(8156-8157):1335-6.
24. Wecksler WR, Mason RS, Norman AW. Specific cytosol receptors for 1,25-dihydroxyvitamin D3 in human intestine. J Clin Endocrinol Metab 1979;48(4):715-7.
25. Segaert S, Degreef H, Bouillon R. Vitamin D receptor expression is linked to cell cycle control in normal human keratinocytes. Biochem Biophys Res Commun 2000;279(1):89-94.
26. Lehmann B, Pietzsch J, Kampf A, Meurer M. Human keratinocyte line HaCaT metabolizes 1alpha-hydroxyvitamin D3 and vitamin D3 to 1alpha,25-dihydroxyvitamin D3 (calcitriol). J Dermatol Sci 1998;18(2):118-27.
27. Garland F, Garland C, Gorham E, Young J, Jr. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-22.
28. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994;23(6):1133-6.
29. Garland C, Garland F, Gorham E. Epidemiology of cancer risk and Vitamin D. In: Holick M, editor. Vitamin D: Molecular Biology, Physiology, and Clinical Applications. New Jersey: Humana; 1999. p. 375-409.
30. Gorham E, Garland C, Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Publ Health 1989;80:96-100.
31. Gorham ED, Garland, FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990;19(4):820-4.
32. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86(2):888-94.
33. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 1998;7(5):391-5.
34. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997;11(13):1961-70.
35. Hewison M, Zehnder D, Bland R, Stewart PM. 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol 2000;25(2):141-8.
36. Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2 [see comments]. Endocrinology 2000;141(1):10-7.
37. Johansen C, Iversen L, Ryborg A, Kragballe K. 1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 2000;114(6):1174-9.
38. James SY, Williams MA, Newland AC, Colston KW. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 1999;32(1):143-54.
39. Welsh J, Van Weelden K, Flanagan L, Byrne I, Nolan E, Narvaez CJ. The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell Biochem 1998;30:245-70.
40. Holick M. Photosynthesis of vitamin D in the skin: effect of environment and life-style variables. Federation Proc 1987;46:1876-82.
41. Webb A, Pilbeam C, Hanofin N, Holick M. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990;51:1075-81.
42. Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab 1999;84(11):3988-90.
43. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
44. Garland C, Shekelle R, Barrett-Connor E. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
45. Garland C, Comstock G, Garland F, Helsing K, Shaw E, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176-8.
46. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes and Control 1997.
47. Schwartz GH, BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10(5A):1307-11.
48. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70(12):2861-9.
49. Corder E, Guess H, Hulka B, Friedman G, Sadler M, Vollmer R, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993;2:467-72.
50. Nomura A, Stemmermann G, Lee J, Kolonel L, Chen T, Turner A, et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control 1998;9(4 [Aug]):425-32.
51. Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvala H, Lou YR, et al. Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 2001;76(1-5):125-34.
52. Brenner B, Russell N, Albrecht S, Davies R. The effect of dietary vitamin D3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Letters 1998;12(7):43-53.
53. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, et al. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 1999;274(32):22739-46.
54. Muller D, Hoenderop JG, Meij IC, van den Heuvel LP, Knoers NV, den Hollander AI, et al. Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECAC1). Genomics 2000;67(1):48-53.
55. Sitrin MD, Bissonnette M, Bolt MJ, Wali R, Khare S, Scaglione-Sewell B, et al. Rapid effects of 1,25(OH)2 vitamin D3 on signal transduction systems in colonic cells. Steroids 1999;64(1-2):137-42.
56. Modi W, Dean M, Pollock D, et al. Chromosomal localization of the calbindin gene. Cytogenet Cell Genet 1991;58::1930.
57. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colon cancer. N Engl J Med 1985;313:1381-4.
58. Buset M, Lipkin M, Winawer S, et al. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res 1986;46:5426-30.
59. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 1988;48:235.
60. Lipkin M, Friedman E, Winawer S, Newmark H. Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 1989;49:248-54.
61. Braun M, Helzlsouer K, Hollis B, Comstock G. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 1995;142:608-11.
62. Martinez M, Giovannucci E, Colditz G, Stampfer M, Hunter D, Speizer F, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. JNCI 1996:88:1375-82.
63. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143(9):907-17.
64. Bostick R, Potter J, Sellers T, McKenzie D, Kushi L, Folsom A. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. Am J Epidemiol 1993;137:1302-17.
65. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 1996;5(11):897-900.
66. Marcus PM, Newcomb PA. The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int J Epidemiol 1998;27(5):788-93.
67. Benito E, Obrador A, Stiggelbout A, Bosch FX, Mulet M, Munoz N, et al. A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer 1990;45(1):69-76.
68. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992;3(5):457-73.
69. Ferraroni M, La Vecchia C, D'Avanzo B, Negri E, Franceschi S, Decarli A. Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 1994;70(6):1150-5.
70. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000;11(5):459-66.
71. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000;9(10):1059-65.
72. Tong WM, Kallay E, Hofer H, Hulla W, Manhardt T, Peterlik M, et al. Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression. Eur J Cancer 1998;34(13):2119-25.
73. Xue L, Newmark H, Yank K, Lipkin M. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet. Nutr Cancer 1996;281.
74. Carroll K, Jacobson L, Eckel L, Newmark H, Dietary calcium, phosphate and vitamin D in relation to mammary carcinogenesis. In: Lipkin M, Newmark H, Kelloff G, editors. Calcium, vitamin D, and prevention of colon cancer. Boca Raton: CRC Press; 1991.
75. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 1999;18(5 Suppl):392S-397S.
76. Xue L, Lipkin M, Newmark H, Wang J. Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst 1999;91(2):176-81.
77. Xue L, Newmark H, Yang K, Lipkin M. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a western-style diet. Nutr Cancer 1996;26(3):281-7.
78. Newmark HL. Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol 1994;364:109-14.
79. Xue L, Newmark H, Wang J, Lipkin M. Suppression of Western-style-diet-induced epithelial cell hyperproliferation in pancreas, prostate and mammary gland of mice by increasing dietary calcium and vitamin D. J Natl Cancer Inst 1999 (In Press).
80. Mawer E, Walls J, Howell A, Davies M, Ratcliffe W, Bundred N. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 1997;82:118-22.
81. Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr 1999;2(3):283-91.
82. Saunders DE, Christensen C, Williams JR, Wappler NL, Lawrence WD, Malone JM, et al. Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone. Anticancer Drugs 1995;6(4):562-9.
83. Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 2000;86(1):40-6.
84. Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, et al. Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25- dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drugs 1993;4(2):201-8.
85. Rustin GJ, Quinnell TG, Johnson J, Clarke H, Nelstrop AE, Bollag W. Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer. Br J Cancer 1996;74(9):1479-81.
86. Schwartz GG, Wang MH, Zang M, Singh RK, Siegel GP. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 1997;6(9):727-32.
87. Hedlund TE, Moffatt KA, Miller GJ. Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31. J Steroid Biochem Mol Biol 1996;58(3):277-88.
88. Hedlund TE, Moffatt KA, Miller GJ. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996;137(5):1554-61.
89. Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 2000;9(3):265-70.
90. Hanchette C, Schwartz G. Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer 1992;70(12):2681-9.
91. Verstuyf A, Segaert S, Verlinden L, Bouillon R, Mathieu C. Recent developments in the use of vitamin D analogues. Expert Opin Investig Drugs 2000;9(3):443-55.
92. Wali RK, Bissonnette M, Khare S, Hart J, Sitrin MD, Brasitus TA. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res 1995;55(14):3050-4.
93. Barsony J, McKoy W, DeGrange DA, Liberman UA, Marx SJ. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J Clin Invest 1989;83(6):2093-101.
94. Taniyama T, Wanibuchi H, Salim EI, Yano Y, Otani S, Nishizawa Y, et al. Chemopreventive effect of 24R,25-dihydroxyvitamin D(3) in N, N'-dimethylhydrazine-induced rat colon carcinogenesis. Carcinogenesis 2000;21(2):173-8.
95. Swami S, Krishnan AV, Feldman D. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 2000;6(8):3371-9.
96. Garabedian M, Ben-Mehkbi H. Rickets and vitamin D deficiency. In: Holick M, editor. Vitamin D: molecular biology, physiology, and clinical applications. Totowa NJ: Humana; 1999. p. 273-86.
97. Rosen CJ, Morrison A, Zhou H, Storm D, Hunter SJ, Musgrave K, et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner 1994;25(2):83-92.
98. Storm D, Eslin R, Porter ES, Musgrave K, Vereault D, Patton C, et al. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab 1998;83(11):3817-25.
99. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. Jama 1999;281(16):1505-11.
100. Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl 1999;73:S2-7.
101. Parfitt A, Gallagher J, Heaney R, Johnson C, Neer R, Whedon G. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982 1982;36:1014-31.
102. National Academy of Sciences-Institute of Medicine-Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington DC: National Academy Press; 1997.
103. Smith E, Hill R, Lehman R, et al. Principles of biochemistry, 7th ed. New York: McGraw-Hill; 1983.
104. Curham GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993:328(12):833-8.
105. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559-63.
106. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22(2):203-17.